imipramine has been researched along with sb 399885 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nikiforuk, A; WesoĊowska, A | 2 |
2 other study(ies) available for imipramine and sb 399885
| Article | Year |
|---|---|
Effects of the brain-penetrant and selective 5-HT6 receptor antagonist SB-399885 in animal models of anxiety and depression.
Topics: Animals; Anti-Anxiety Agents; Antidepressive Agents; Antidepressive Agents, Tricyclic; Anxiety; Avoidance Learning; Blood-Brain Barrier; Brain; Choice Behavior; Conflict, Psychological; Depression; Diazepam; Drinking Behavior; Electroshock; Hindlimb Suspension; Imipramine; Male; Mice; Motor Activity; Piperazines; Postural Balance; Rats; Rats, Wistar; Receptors, Serotonin; Serotonin Antagonists; Sulfonamides; Swimming | 2007 |
The selective 5-HT(6) receptor antagonist SB-399885 enhances anti-immobility action of antidepressants in rats.
Topics: Adrenergic Uptake Inhibitors; Animals; Antidepressive Agents; Bupropion; Citalopram; Dopamine Uptake Inhibitors; Drug Synergism; Imipramine; Injections, Intraperitoneal; Male; Moclobemide; Monoamine Oxidase Inhibitors; Motor Activity; Piperazines; Rats; Rats, Wistar; Receptors, Serotonin; Selective Serotonin Reuptake Inhibitors; Serotonin Antagonists; Sulfonamides | 2008 |